Edward T Mathers
CIK 1328625 · EVP, Corporate Dev. & Venture · last filed 2026-08-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GLUE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
19TH FLOOR
NEW YORK, NY 10011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OKUR | Director | 15,310 | $2.70 | $41.3K | $0 | 8 | 2026-08-11 |
| MBX | Director | 1,023,103 | $52.88 | $54.10M | $8.00M | 4 | 2026-06-05 |
| TRVI | Director | 948,948 | $13.21 | $12.54M | $0 | 9 | 2026-06-04 |
| RYTM | Director | 21,168 | $91.42 | $1.94M | $0 | 14 | 2026-03-16 |
| KRRO | 10%+ Owner | 1,297,893 | $13.41 | $17.41M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 6,035,038 | $30.48 | $183.95M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 488,982 | $16.35 | $7.99M | -$24.5K | 6 | 2025-10-06 |
| SNTI | Director | — | $0.17 | — | $0 | 5 | 2025-06-27 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| Inozyme Pharma, Inc. (INZY) Delisted | Director | — | $4.00 | — | $0 | 5 | 2024-06-20 |
| SVRA | 10%+ Owner | 24,471,264 | $4.75 | $116.12M | $1000.0K | 1 | 2023-07-19 |
| SYNLOGIC, INC. (SYBX) Delisted | Director | — | $0.69 | — | $0 | 8 | 2023-06-26 |
| OnKure Therapeutics, Inc. (RPHM) Delisted | Director | — | $18.20 | — | $0 | 3 | 2023-06-08 |
| Akouos, Inc. (AKUS) Delisted | Director | — | $13.29 | — | $0 | 3 | 2022-12-02 |
| MIRM | Director | — | $83.84 | — | $0 | 3 | 2022-06-06 |
| GLUE | 10%+ Owner | 5,973,296 | $10.53 | $62.90M | $19.95M | 1 | 2021-06-30 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | — | — | — | $0 | 4 | 2020-04-03 |
| SYNLOGIC, INC. (MIRN) Delisted | Director | — | — | — | $0 | 1 | 2016-09-06 |
| MEDI | EVP, Corporate Dev. & Venture | — | $33.77 | — | $0 | 2 | 2007-06-19 |
Recent Filings · Page 7 of 9
84 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-11 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2021-06-08 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2021-04-12 | OnKure Therapeutics, Inc. (RPHM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-24 | Inozyme Pharma, Inc. (INZY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | MIRM | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | SYNLOGIC, INC. (SYBX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-06-21 | RYTM | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.